p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias

H. Döhner; Konstanze Fischer; Martin Bentz; Klavs Würgler Hansen; Axel Benner; G Cabot; Daniela Diehl; Richard F. Schlenk; Johannes Coy; Stephan Stilgenbauer

doi:10.1182/blood.v85.6.1580.bloodjournal8561580

p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias

Identifier:nobleid.org/w1/20260524/7F306F3D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/7F306F3D.svg?ark=w1%2F20260524%2F7F306F3D)](https://nobleid.org/work/w1/20260524/7F306F3D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias

Identifier:nobleid.org/w1/20260524/7F306F3D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/7F306F3D.svg?ark=w1%2F20260524%2F7F306F3D)](https://nobleid.org/work/w1/20260524/7F306F3D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work